Antifungal dosing in critically ill patients

被引:1
|
作者
Bergman S.J. [1 ]
Tyagi I. [1 ]
Ronald K. [1 ]
机构
[1] Division of Infectious Diseases, Southern Illinois University School of Medicine, Springfield, IL 62794, 701 North 1st Street
关键词
Amphotericin B; Anidulafungin; Antifungals; Caspofungin; Combinations; Critical care; Dose; Echinocandin; Fluconazole; Flucytosine; ICU; Itraconazole; Lipid formulations; Micafungin; Pharmacodynamics; Pharmacokinetics; Posaconazole; Triazole; Voriconazole;
D O I
10.1007/s12281-010-0012-z
中图分类号
学科分类号
摘要
This article reviews appropriate dosing for antifungals and emphasizes factors specific to the critically ill patient, along with drug pharmacokinetics and pharmacodynamics. The rationale for doses of the echinocandins (caspofungin, micafungin, anidulafungin), triazoles (fluconazole, voriconazole, itraconazole, posaconazole), amphotericin B (including lipid formulations), and flucytosine are discussed. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码:78 / 86
页数:8
相关论文
共 50 条
  • [41] VANCOMYCIN DOSING AND INITIAL TROUGH LEVELS IN CRITICALLY ILL PATIENTS
    Parekh, Trisha
    Gowda, Ashwin
    Shah, Shiwan
    Nishi, Shawn
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (12) : U265 - U266
  • [42] The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
    Ulldemolins, Marta
    Roberts, Jason A.
    Rello, Jordi
    Paterson, David L.
    Lipman, Jeffrey
    [J]. CLINICAL PHARMACOKINETICS, 2011, 50 (02) : 99 - 110
  • [43] Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy
    Felton, T. W.
    Roberts, J. A.
    Lodise, T. P.
    Van Guilder, M.
    Boselli, E.
    Neely, M. N.
    Hope, W. W.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 4094 - 4102
  • [44] Personalized antibiotic dosing for the critically ill
    Roberts, Jason A.
    Roger, Claire
    De Waele, Jan J.
    [J]. INTENSIVE CARE MEDICINE, 2019, 45 (05) : 715 - 718
  • [45] Personalized antibiotic dosing for the critically ill
    Jason A. Roberts
    Claire Roger
    Jan J. De Waele
    [J]. Intensive Care Medicine, 2019, 45 : 715 - 718
  • [46] Cotrimoxazole - optimal dosing in the critically ill
    Glen R Brown
    [J]. Annals of Intensive Care, 4
  • [47] Cotrimoxazole - optimal dosing in the critically ill
    Brown, Glen R.
    [J]. ANNALS OF INTENSIVE CARE, 2014, 4
  • [48] Antifungal Stewardship in Light of the Updated Evidence on Untargeted Antifungal Treatment in Critically Ill Patients
    Vincenzo Russotto
    Andrea Cortegiani
    Santi Maurizio Raineri
    Cesare Gregoretti
    Antonino Giarratano
    [J]. Current Clinical Microbiology Reports, 2016, 3 (4) : 171 - 172
  • [49] Antifungal Stewardship in Light of the Updated Evidence on Untargeted Antifungal Treatment in Critically Ill Patients
    Russotto, Vincenzo
    Cortegiani, Andrea
    Raineri, Santi Maurizio
    Gregoretti, Cesare
    Giarratano, Antonino
    [J]. CURRENT CLINICAL MICROBIOLOGY REPORTS, 2016, 3 (04): : 171 - 172
  • [50] β-Lactams Dosing in Overweight Critically Ill Patients: Are We Driving in the Dark?
    Aubron, Cecile
    Corallo, Carmela
    [J]. CRITICAL CARE MEDICINE, 2017, 45 (05) : 923 - 925